This clinical trial is focused on studying the effects of oral antibiotics on preventing infections and wound complications after an obstetric perineal tear, which is a type of injury that can occur during childbirth. The treatment being tested is a medication called Bioclavid, which contains two active ingredients: amoxicillin and clavulanic acid. These are commonly used antibiotics that help fight bacterial infections. The study will compare the effects of this medication to a placebo, which is a substance with no active ingredients, to see if the antibiotics can reduce the risk of infection and help the wound heal better.

The purpose of the study is to determine whether taking three doses of these oral antibiotics can lower the chances of developing an infection or experiencing wound separation after a perineal tear. Participants in the study will be randomly assigned to receive either the antibiotics or the placebo. The study is designed to be double-blinded, meaning neither the participants nor the researchers will know who is receiving the actual medication or the placebo, to ensure unbiased results.

Throughout the study, researchers will monitor the participants for any signs of infection or wound complications. They will also check for any other issues that might arise, such as incontinence, pelvic prolapse, pain, or sexual dysfunction, both one week and one year after the treatment. The study aims to provide valuable information on whether antibiotics can be an effective way to prevent complications after childbirth-related perineal tears.